9-114407949-C-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_015404.4(WHRN):āc.1696G>Cā(p.Val566Leu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,599,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015404.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WHRN | NM_015404.4 | c.1696G>C | p.Val566Leu | missense_variant, splice_region_variant | 8/12 | ENST00000362057.4 | NP_056219.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WHRN | ENST00000362057.4 | c.1696G>C | p.Val566Leu | missense_variant, splice_region_variant | 8/12 | 1 | NM_015404.4 | ENSP00000354623.3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000176 AC: 4AN: 227422Hom.: 0 AF XY: 0.00000815 AC XY: 1AN XY: 122768
GnomAD4 exome AF: 0.00000414 AC: 6AN: 1447624Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 718718
GnomAD4 genome AF: 0.000112 AC: 17AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2022 | ClinVar contains an entry for this variant (Variation ID: 45662). This variant has not been reported in the literature in individuals affected with WHRN-related conditions. This variant is present in population databases (rs189654215, gnomAD 0.03%). This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 566 of the WHRN protein (p.Val566Leu). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 05, 2011 | Val566Leu in exon 8 of DFNB31: This variant is not expected to have clinical sig nificance because dog, cat, cow, chicken, frog, elephant, and opossum have a leu cine at this position despite high nearby amino acid conservation. The Val566Leu variant occurs in the third to last three base of the exon which is part of the splicing consensus sequence. However, splicing prediction programs suggest no i mpact to splicing. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at